Picture of ReproCell logo

4978 ReproCell Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for ReproCell, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1,015-812-574-304-28.9
Depreciation
Amortisation
Non-Cash Items182-134-14.327.1-265
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital76.823628287246
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities-690-649-246-141-11.4
Capital Expenditures-120-59.9-43.4-150-171
Purchase of Fixed Assets
Other Investing Cash Flow Items1,338-1,357-2,101-937576
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities1,218-1,417-2,144-1,087404
Financing Cash Flow Items6.05
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6.574.412,385483544
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash473-1,98435.6-7221,024